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Summary and Implications 
 Objectives of this field investigation were to examine 
the etiology and mastitis infection dynamics in a 60 cow 
herd in danger of market loss, prioritize and implement 
prevention strategies, and evaluate the efficacy of 
recommended and extended therapy (S. aureus only) with 
pirlimycin hydrochloride (Pirsue, Pfizer Animal Health) for 
gram positive intramammary infections (IMI) . Initial 
percentages (October) of cows (quarters) uninfected or 
infected with Staph. aureus, Strep. dysgalactiae, alpha 
hemolytic strep., and  Strep. uberis, were  42(65); 33(15%); 
20(9); 3(1); and 2(0.4), respectively.  Overall streptococci 
cure rates were 91% and 89% of cows and quarters, 
respectively and was higher than average published values 
(65-70%). Cure rates for Staph. aureus (extended pirlimycin 
therapy) were very low at 7% and 4% of cows and quarters, 
respectively. Overall results showed excellent therapy 
response for Strep. IMI but very low S. aureus cure rates. 
However, some therapy success coupled with critical and 
mandatory prevention strategies (including a strict milking 
order) resulted in a 50% decrease in SCC by January and 
limited new infections. Failure to continue these proper 
prevention strategies resulted in many new IMI and high 
herd SCC in February, and demonstrates the mandatory 
requirements for proper mastitis prevention strategies 
(including a milking order) in a comprehensive mastitis and 
milk quality program . 
 * Lorillee Schultz presented this original field trial and 
research at the 2005 American Dairy Science Association 
meeting and was awarded first place in the Undergraduate 
Original Research Presentation competition. 
 
Objectives 
 The objectives of this field investigation were to: 1) 
examine the etiology and mastitis infection dynamics in a 60 
cow herd during the fall-winter- spring of 2004-05 whose 
normal herd bulk tank SCC was 500,000 cells/ml but had 
jumped to >750,000 cells/ml for 8 months; 2) investigate 
herd management and procedures and develop and prioritize 
necessary changes for mastitis prevention; and 3) evaluate 
the efficacy of recommended and extended therapy with 
pirlimycin hydrochloride (Pirsue, Pharmacia/Upjohn Co. 
Kalamazoo, MI) for gram positive intramammary infections 
(IMI) . 
 
Materials and Methods 
 This case study involved a 60 cow dairy (very high 
genetic potential) whose DHIA average somatic cell count 
(SCC) was > 750,000 cells/ml (linear scores 4.3-5.2) for 
eight months prior to study initiation.  Initial study DHI 
SCC showed a 948,000 herd average SCC with 56% of the 
cows >300,000 (36% >1,130,000). Seventy-five percent of 
first lactation animals had SCC < 140,000 and represented 
an excellent uninfected nucleus for the herd. Major priorities 
were to assess the initial infection status of all animals, keep 
milk sold under the legal SCC limit, prevent new infections, 
and reduce SCC through successful targeted therapy.  
 A California mastitis test was conducted and aseptic 
quarter milk samples on every quarter of every cow were 
obtained in late October (first screen). All samples were 
cultured according to NMC protocols and MIC’s were 
conducted on representative organism samples. Based on 
these initial cultures, a new milking order was immediately 
established to stop infection spread. Uninfected cows were 
milked first, followed by Strep-infected cows, with Staph. 
aureus cows milked last. Only one new infection (based on 
DHI-SCC) occurred before the therapy trial began 8 weeks 
later, attesting to the compliance and success of a defined 
milking order. Within 4 weeks of initial sampling, an on-site 
herd visit at milking time was conducted which included 
obtaining a second set of aseptic quarter milk samples.  
Major areas for observation and evaluation were teat health 
assessment, milking procedures, milking equipment, cow 
environment, and animal nutrition and health.  
 Average teat score was 2.4 (1=normal, 2=smooth ring, 
3=rough ring, 4 = very rough ring). Although many teats 
were normal and healthy, there was evidence of some 
cracking and hyperkeratosis as a result of overmilking, and 
may account for Strep. dysgalactiae and Staph. aureus being 
present in the herd.  
 Milking procedures showed animals being washed with 
individual towels dipped in water containing a germicide, no 
drying or forestripping, and fair teat coverage with post 
milking teat dip. Cows were not receiving adequate 
stimulation and excessive milk hose manipulation and 
holding pressure on units resulted in delayed milk let downs 
and excessive overmilking, respectively. Overall milking 
procedures evaluation revealed inadequate udder 
stimulation, no drying of teats, and improper prep lag 
timing.  Based on these observations, corrective milking 
procedures were instituted using a 2 cow- 6 step coordinated 
approach. 
 Milking system was sized and arranged properly with 
adequate vacuum pump capacity and reserve, excellent 
pulsator function, and proper line and milking vacuums. 
Regulator only had 80% efficiency due to dirty air dumps, 
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and monthly corrective cleaning steps were instituted. 
Excessive time at high teat end vacuum was experienced at 
end of milking due to improper stimulation / overmilking. 
 Cow environment was rated excellent. Tie stalls were 
deep bedded with fresh straw and new freestalls were 
bedded with fresh sand. Over 95% of animas scored 
cleanliness 1 or 2 (1= very clean, 5 = very dirty) with only a 
few 3’s. Hocks were scored on a 1-5 scale ( 1= excellent, 5 
= abscessed) and ranged from 1-3 with most cows < 2. Body 
condition score averaged 3 and was very consistent and 
appropriate across the herd.  
 MIC data showed all organisms showing excellent 
sensitivity to pirlimycin so it was chosen as the antibiotic 
for treatment. Nine Strep. cows (20 quarters) were treated 
using recommended pirlimycin therapy (one 10 ml plastet 
50 mg pirlimycin HCl  (Pirsue, Pfizer, Inc.)) at 24-hour 
intervals for two days. Eleven  Staph. aureus cows (19 
quarters) were treated using an extended pirlimycin therapy 
(one plastet every 24 hours for eight days). 7 cows were 
dried off and 2 were sold for unrelated reasons. Individual 
cow SCC were run 28 days post treatment and the herd was 
visited 40 days post treatment to obtain aseptic quarter milk 
samples and assess prevention changes and therapy results.  
 
Results 
 Herd culture results prior to the therapy trial are shown 
in Table 1. Percentages of cows (quarters) uninfected or 
infected with Staph. aureus, Strep. dysgalactiae, alpha 
hemolytic strep., and  Strep. uberis, were  42(65); 33(15%); 
20(9); 3(1); and 2(0.4), respectively. Therapy cure rates for 
different organisms are shown in Table 2. Overall 
streptococci cure rates were 91% and 89% of cows and 
quarters, respectively and was higher than average 
published values (65-70%). Cure rates for Staph. aureus 
(extended pirlimycin therapy) were very low at 7% and 4% 
of cows and quarters, respectively. This is lower than 
average published values although there is tremendous 
within and across herd variability due to duration and SCC 
level of existing infected quarter, as well as other herd 
stressor factors. Many of the animals in this herd had a long 
chronic high SCC history. Successful therapy of Strep. IMI 
coupled with prevention of new infections through a strict 
milking order and other milking changes resulted in a 
January SCC of 484,000 but still showed ~ 50% of animals 
> 300,000. February DHI SCC was 832,000 with 5 new 
Staph. aureus and 2 new alpha strep. infections found during 
the herd visit and therapy follow up cultures. Herd 
observations showed milking practices not being followed 
and no strict milking order, and communication issues 
between the herd manager and employee (milker– 
herdsperson). With the achievement of a lower SCC in 
January, the herd relaxed its prevention practices even 
though it was specified how critical these were. The study is 
still ongoing and includes monthly monitoring of DHIA 
information, culturing suspected new infections, new dry 
cow treatment protocols, selling some chronic cows, and 
investigating new treatment options. Overall results showed 
excellent therapy response for Strep. IMI but very low S. 
aureus cure rates. However, some therapy success coupled 
with critical and mandatory prevention strategies resulted in 
a 50% decrease in SCC and limited new infections. Failure 
to continue proper prevention strategies resulted in many 
new IMI and high herd SCC, and demonstrates the 
mandatory requirements for proper mastitis prevention 
strategies (including a milking order) in a comprehensive 
mastitis and milk quality program. 
 
 
 
Table 1. Herd culture results prior to therapy based on 2 different samplings. 
 
 No. (%) cows No. (%) quarters 
Uninfected 25  (42%) 156  (65%) 
Staph. Aureus. 20 (33%) 35 (15%) 
Strep. Dysgalactiae 12  (20%) 21 ( 9%) 
Strep. Alpha hemolytic 2  (3%) 3  (1%) 
Strep. Uberis 1 (2%) 1  (.4%) 
   
 
 
Table 2. Cure rates for gram + IMI using recommended (*) or extended pirlimycin therapy (**). 
 
 Strep. dysgalactiae * Strep. (alpha hemolytic) * Strep. uberis * Staph. aureus** 
Cow cure rate 100% 50% 100% 7% 
Quarter cure rate 100% 33% 100% 4% 
 
 *Recommended therapy = treated intramammary 2x with one 10 ml plastet 50 mg pirlimycin HCl 24 hrs apart;   
**Extended therapy = 1 tube pirlimycin / day for 8 days (24 hrs apart) 
 
